Kantonsspital St.Gallen
login

publications

Thomas Hundsberger

title  
 
Roth P, Hottinger A F, Hundsberger T, Läubli H, Schucht P, Reinert M, Mamot C, Roelcke U, Pesce G, Hofer S, Weller M. A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults. Swiss Med Wkly 2020; 150:w20256.
   
Baumer A, Hundsberger T. Akutes Karpaltunnelsyndrom durch Thrombose einer persistierenden Arteria mediana. Swiss medical forum 2020; 20:86-88.
   
Iseli T, Fischer G, Panje C, Glatzer M, Hundsberger T, Rothermundt C, Schmidt B, Sirén C, Plasswilm L, Putora P M. Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology. Oncology 2020; 98:438-444.
   
Lagler F B, Moder A, Rohrbach M, Hennermann J, Mengel E, Gökce S, Hundsberger T, Rösler K M, Karabul N, Huemer M. Extent, impact, and predictors of diagnostic delay in Pompe disease: A combined survey approach to unveil the diagnostic odyssey. JIMD Rep 2019; 49:89-95.
   
Panje C, Putora P M, Hundsberger T, Hottinger A F, Roelcke U, Pesce G, Herrmann E, Matter-Walstra K. Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study. Swiss Med Wkly 2019; 149:w20153.
   
Hundsberger T, Schoser B, Leupold D, Rösler K M, Putora P M. Comparison of recent pivotal recommendations for the diagnosis and treatment of late-onset Pompe disease using diagnostic nodes-the Pompe disease burden scale. J Neurol 2019; 266:2010-2017.
   
Scheidegger O, Leupold D, Sauter R, Findling O, Rösler K M, Hundsberger T. 36-Months follow-up assessment after cessation and resuming of enzyme replacement therapy in late onset Pompe disease: data from the Swiss Pompe Registry. J Neurol 2018;.
   
Lüscher D, Diethelm M, Hundsberger T, Hitz F. Fieber bei monoklonaler Gammopathie und Immunneuropathie – ein differenzialdiagnostischer Sple(e)n. Praxis (Bern 1994) 2018; 107:329-333.
   
Wirsching H G, Tabatabai G, Roelcke U, Hottinger A F, Jörger F, Schmid A, Plasswilm L, Schrimpf D, Mancao C, Capper D, Conen K, Hundsberger T, Caparrotti F, von Moos R, Riklin C, Felsberg J, Roth P, Jones D T W, Pfister S, Rushing E J, Abrey L, Reifenberger G, Held L, von Deimling A, Ochsenbein A, Weller M. Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial. Ann Oncol 2018; 29:1423-1430.
   
Hottinger A F, Ben Aissa A, Espeli V, Squiban D, Dunkel N, Vargas M I, Hundsberger T, Mach N, Schaller K, Weber D C, Bodmer A, Dietrich P Y. Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma. Br J Cancer 2018;.
   
Astaras C, de Micheli R, Moura B, Hundsberger T, Hottinger A F. Neurological Adverse Events Associated with Immune Checkpoint Inhibitors: Diagnosis and Management. Curr Neurol Neurosci Rep 2018; 18:3.
   
Schilling C, Weilenmann D, Diener S, Hundsberger T. [A Rare Cause for Transient Aphasia after Conorary Angiography]. Praxis (Bern 1994) 2018; 107:531-534.
   
Hundsberger T, Weller M. Bevacizumab: Zankapfel der Glioblastomtherapie. Praxis (Bern 1994) 2017; 106:415-420.
   
Panje C, Glatzer M, von Rappard J, Rothermundt C, Hundsberger T, Zumstein V, Plasswilm L, Putora P M. Applied Swarm-based medicine: collecting decision trees for patterns of algorithms analysis. BMC Med Res Methodol 2017; 17:123.
   
Hundsberger T, Reardon D A, Wen P Y. Angiogenesis inhibitors in tackling recurrent glioblastoma. Expert Rev Anticancer Ther 2017;.
   
van der Ploeg A T, Kruijshaar M E, Toscano A, Laforêt P, Angelini C, Lachmann R H, Pascual Pascual S I, Roberts M, Rösler K, Stulnig T, van Doorn P A, Van den Bergh P Y K, Vissing J, Schoser B, . European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience. Eur J Neurol 2017; 24:768-e31.
   
Hundsberger T. Herpes zoster induced predominant motor lumbal plexopathy in a lung cancer patient. Austin J Neurol Disord Epilepsy 2017; 4:1036.
   
Vehoff J, Haegele-Link S, Humm A, Mueller S K, Sauter R, Tettenborn B, Hundsberger T. Heart rate variability decreases after 3 months of sustained treatment with fingolimod. J Neurol 2017; 264:2313-2317.
   
Leupold D, Schilg-Hafer L, Felbecker A, Kim O C H, Tettenborn B, Hundsberger T. Unilateral tongue myokymia - A rare topodiagnostic sign of different clinical conditions. J Clin Neurosci 2017;.
   
Hundsberger T. Diagnostischer Stellenwert der Nervensonographie beim Karpaltunnelsyndrom: Nervenengpasssyndrom. INFO Neurologie & Psychiatrie 2016; 14:12-15.
   
Hundsberger T, Hottinger A F, Roelcke U, Roth P, Migliorini D, Dietrich P Y, Conen K, Pesce G, Hermann E, Pica A, Gross M W, Brügge D, Plasswilm L, Weller M, Putora P M. Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes. J Neurooncol 2016; 126:175-183.
   
Leupold D, Felbecker A, Tettenborn B, Hundsberger T. Nerve Ultrasound as a Decisive Tool in Nonsystemic Vasculitic Neuropathy: A Case Report. Case Rep Neurol 2016; 8:108-14.
   
Hundsberger T. Supportive Therapie in der Neuroonkologie: Palliation bei Hirntumoren. INFO Neurologie & Psychiatrie 2016; 4:22-27.
   
Leupold D, Boggian K, Weber J, Tettenborn B, Hundsberger T. Management der akuten Meningitis und Enzephalitis: Ein klinischer Leitfaden. Praxis (Bern 1994) 2016; 105:1471-1478.
   
Hundsberger T, surbeck w, Hader C, Putora P M, Conen K, Roelcke U. [Meningioma: management of the most common brain tumour]. Praxis (Bern 1994) 2016; 105:445-51.
   
Hottinger A F, Perez L, Hägele-Link S, Hundsberger T. [Neurological complications of anticancer treatments]. Rev Med Suisse 2016; 12:840-3.
   
Hundsberger T, Hottinger A F. Behandlungsoptionen von Hirnmetastasen: Neue Optionen durch orale und molekulare Therapeutika. info@onkologie 2015; 5:5-7.
   
Leupold D, Krammer W, Dollmaier G, Hundsberger T. Neurologische Aspekte bei HIV und Syphilis: Wie manifestieren sich die Infektionserkrankungen am Nervensystem. InFo Neurologie & Psychiatrie 2015; 13:2-7.
   
Müller K, Henke G, Pietschmann S, van Gool S, De Vleeschouwer S, von Bueren A O, Compter I, Friedrich C, Matuschek C, Klautke G, Kortmann R D, Hundsberger T, Baumert B G. Re-irradiation or re-operation followed by dendritic cell vaccination? Comparison of two different salvage strategies for relapsed high-grade gliomas by means of a new prognostic model. J Neurooncol 2015; 124:325-32.
   
Hundsberger T, Rösler K M, Findling O. Long-Term Interruption of Enzyme Replacement Therapy with rhGAA in Pompe Disease Leads to Irreversible Clinical Decline. J Neuromuscul Dis 2015; 2:S20.
   
Korfel A, Thiel E, Martus P, Möhle R, Griesinger F, Rauch M, Röth A, Hertenstein B, Fischer T, Hundsberger T, Mergenthaler H G, Junghanß C, Birnbaum T, Fischer L, Jahnke K, Herrlinger U, Roth P, Bamberg M, Pietsch T, Weller M. Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma. Neurology 2015; 84:1242-8.
   
Desax M C, Hundsberger T, Rothermundt C, Omlin A, Gillessen Sommer S. Restless Legs Syndrome—An Emerging Potential Side Effect of Enzalutamide: Report of 2 Cases. Clin Genitourin Cancer 2015; 13:e385-6.
   
Putora P M, Ess S, Panje C, Hundsberger T, van Leyen K, Plasswilm L, Früh M. Prognostic significance of histology after resection of brain metastases and whole brain radiotherapy in non-small cell lung cancer (NSCLC). Clin Exp Metastasis 2015; 32:143-9.
   
Schmid S, Gillessen Sommer S, Binet I, Brändle M, Engeler D S, Greiner J, Hader C, Heinimann K, Kloos P, Krek W, Krull I, Stöckli S, Sulz M, van Leyen K, Weber J, Rothermundt C, Hundsberger T. Management of von Hippel-Lindau Disease: An Interdisciplinary Review. Oncol Res Treat 2014; 37:761-771.
   
Schilg-Hafer L, Hägele-Link S, Felbecker A, Weber J, Tettenborn B, Gers B, Hundsberger T. Nervensonographie intraneuraler Ganglien als Ursache schmerzhafter N.-peronaeus-Paresen: eine Fallserie. PRAXIS 2014; 24:1433-1438.
   
Hundsberger T, Rösler K M, Findling O. Cessation and resuming of alglucosidase alfa in Pompe disease: a retrospective analysis. J Neurol 2014; 261:1684-1690.
   
Hundsberger T, Omlin A, Hägele-Link S, Vehoff J, Strasser F. Autonomic Dysfunction in Cancer Cachexia Coincides With Large Fiber Polyneuropathy. J Pain Symptom Manage 2014; 48:611-618.
   
Omlin A, stienen m, Brügge D, Fretz C, Gillessen Sommer S, Hundsberger T. Maligne spinale Kompression: Prävention, Erkennung und «State of the Art»-Behandlung. SMF 2014; 14:820-825.
   
Müller K, Henke G, Compter I, von Bueren A O, Friedrich C, Janssens G, Kramm C M, Hundsberger T, Paulsen F, Kortmann R D, Zwiener I, Baumert B G. External validation of a prognostic model estimating the survival of patients with recurrent high-grade gliomas after reirradiation. Pract Radiat Oncol 2014; 5:e143-50.
   
Hundsberger T, Weber J, Brügge D, Sèdille-Mostafaie N, Hitz F. Leptomeningeal lymphomatosis from large granular lymphocyte leukaemia. J Neurol 2014; 261:1221-2.
   
Hundsberger T, Tonder M, Hottinger A, Brügge D, Roelcke U, Putora P M, Stupp R, Weller M. Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patients. J Neurooncol 2014; 118:321-328.
   
Hottinger A F, Aissa A B, Espeli V, Squiban D, Dunkel N, Vargas M I, Hundsberger T, Mach N, Schaller K, Weber D C, Bodmer A, Dietrich P Y. Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma. Br J Cancer 2014; 110:2655-2661.
   
Hundsberger T, Roth P, Roelke U. Neurologische Komplikationen bei onkologischen Patienten. Praxis 2014 2014; 103:1009-1016.
   
Schilg L, Hägele-Link S, Felbecker A, Gers B, Weber J, Tettenborn B, Hundsberger T. [Nerve sonography of intraneural ganglia as cause painful peroneal palsies: a case series]. Praxis (Bern 1994) 2014; 103:1433-8.
   
Hundsberger T. Neuroborreliosis mimicking leptomeningeal carcinomatosis in a patient with breast cancer: A case report. Journal of investigative medicine 2014; 2014:1-4.
   
Putora P M, Panje C, Papachristofilou A, Pra A, Hundsberger T, Plasswilm L. Objective consensus from decision trees. Radiat Oncol 2014; 9:270.
   
Hundsberger T, Roth P, Roelcke U. [Neurological complications in cancer patients]. Praxis (Bern 1994) 2014; 103:1009-16.
   
Hundsberger T. The Swiss Working Group Brain Tumor. Eur Assoc neurooncol Mag 2014; 4:134-135.
   
Fischer S, Weber J, Senn-Schönenberger I, cerny t, Hundsberger T. Neuroborreliosis Mimicking Leptomeningeal Carcinomatosis in a Patient With Breast Cancer: A Case Report. J Investig Med High Impact Case Rep 2014; 2:2324709614529417.
   
Hundsberger T, Weber J, Tettenborn B, Walch J. Radiation-induced cavernoma after total body irradiation and haematopoietic stem cell transplantation in an adult patient suffering from acute myeloid leukaemia. Case Reports in Neurology 2013; 5:91-97.
   
Hundsberger T. Management der Von Hippel-Lindau Erkrankung: Eine interdisziplinäre Herausforderung. info@onkologie 2013; 04:24-28.
   
Hundsberger T, Brügge D, Putora P M, Weder P, Weber J, Plasswilm L. Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas. J Neurooncol 2013; 112:133-9.
   
hochstrasser a, Hundsberger T, Siano M. Secondary spinal anaplastic ependymoma ten years after treatment of Hodgkin’s disease. Schweiz. Krebs Bulletin 2013; 2:175-178.
   
Walch J, Tettenborn B, Weber J, Hundsberger T. Radiation-induced cavernoma after total body irradiation and haematopoietic stem cell transplantation in an adult patient suffering from acute myeloid leukaemia. Case Rep Neurol 2013; 5:91-7.
   
Roelcke U, Bruehlmeier M, Hefti M, Hundsberger T, Nitzsche E U. F-18 choline PET does not detect increased metabolism in F-18 fluoroethyltyrosine-negative low-grade gliomas. Clin Nucl Med 2012; 37:e1-3.
   
Korfel A, Weller M, Martus P, Roth P, Klasen H A, Roeth A, Rauch M, Hertenstein B, Fischer T, Hundsberger T, Leithäuser M, Birnbaum T, Kirchen H, Mergenthaler H G, Schubert J, Berdel W, Birkmann J, Hummel M, Thiel E, Fischer L. Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial. Ann Oncol 2012; 23:2374-2380.
   
Hundsberger T. Aktuelle Therapie des Glioblastoms: Noch immer sehr schlechte Prognose. info@onkologie 2011; 06:18-20.
   
Hundsberger T. Die Problematik der Enzymersatztherapie beim Morbus Pompe (Glykogenose Typ II): Eine medizinische Einschätzung. Schweiz Med Forum 2011; 11:427-429.
   
Hundsberger T, Cogliatti S B, Kleger G R, Fretz C, Gähler A, anliker m, Fournier J Y, von Moos R, Tettenborn B, Driessen C. Intravascular lymphoma mimicking cerebral stroke: report of two cases. Case Rep Neurol 2011; 3:278-283.
   
Hundsberger T, erdelyi b, Hohl U, Rösler K M. Die Glykogenose Typ II: Morbus Pompe. Schweizer Archiv für Neurologie und Psychiatrie 2010; 161:55-59.
   
Thiel E, Korfel A, Martus P, Kanz L, Griesinger F, Rauch M, Röth A, Hertenstein B, von Toll T, Hundsberger T, Mergenthaler H G, Leithäuser M, Birnbaum T, Fischer L, Jahnke K, Herrlinger U, Plasswilm L, Nägele T, Pietsch T, Bamberg M, Weller M. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncol 2010; 11:1036-47.
   
Hundsberger T, Müller S, Sommacal A, Fretz C, Tettenborn B. Koinzidenz von ischämischer Enzephalopathie und essentieller Thrombozythämie: zerebrale kortikale Venenthrombose ?. Schweizer Archiv für Neurologie und Psychiatrie 2010; 161:262-265.
   
gautschi o, Cadosch D, Collen T D, Land M, hoederath p, hildebrandt g, Fournier J Y, Hundsberger T. [Glioblastoma Multiforme - New Hope due to Modern Therapeutical Approaches.]. Praxis (Bern 1994) 2010; 99:295-308.
   
Glas M, Hundsberger T, Stuplich M, Wiewrodt D, Kurzwelly D, Nguyen-Huu B, Rasch K, Herrlinger U. Nimustine (ACNU) plus teniposide (VM26) in recurrent glioblastoma. Oncology 2009; 76:184-9.
   
Roelcke U, Bruehlmeier M, Hefti M, Hundsberger T. Imaging blood-brain barrier transporters in low-grade glioma patients with positron emission tomography, tyrosine and choline. Schweiz Arch Neurol Psychiatr 2009; 7:312-313.
   
Yaldizli O, Coco O, Hundsberger T, Tettenborn B. Pain in the sole of the foot. Have you suspected its cause in the knee?. MMW Fortschritte der Medizin 2009; 151:5.
   
Kamm C P, Mattle H P, SWABIMS Study Group . SWiss Atorvastatin and interferon Beta-1b trial In Multiple Sclerosis (SWABIMS)--rationale, design and methodology. Trials 2009; 10:115.
   
Tettenborn B, Yaldizli O, Hundsberger T. Pain in the sole of the foot. Have you suspected its cause in the knee?. MMW Fortschr Med. 2009; 151(19):5.
   
Wiewrodt D, Nagel G, Dreimüller N, Hundsberger T, Perneczky A, Kaina B. MGMT in primary and recurrent human glioblastomas after radiation and chemotherapy and comparison with p53 status and clinical outcome. International journal of cancer. Journal international du cancer 2008; 122:1391-9.
   
Nitschke S, Hundsberger T, Hägele-Link S, Tettenborn B. Therapy refractory Voltage-gated potassium channel antibody (VGKC-Ab) negative neuromyotonia with generalized lymphadenopathy. Schweizer Archiv für Neurologie und Psychiatrie 2007; 158:.
   
Koch D, Hundsberger T, Boor S, Kaina B. Local intracerebral administration of O(6)-benzylguanine combined with systemic chemotherapy with temozolomide of a patient suffering from a recurrent glioblastoma. Journal of neuro-oncology 2007; 82:85-9.
   
Hau P, Koch D, Hundsberger T, Marg E, Bauer B, Rudolph R, Rauch M, Brenner A, Rieckmann P, Schuth J, Jauch T, Koch H, Bogdahn U. Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma. Neurology 2007; 68:688-90.
   
Herrlinger U, Rieger J, Koch D, Loeser S, Blaschke B, Kortmann R D, Steinbach J P, Hundsberger T, Wick W, Meyermann R, Tan T C, Sommer C, Bamberg M, Reifenberger G, Weller M. Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006; 24:4412-7.
   
Hundsberger T, Wiewrodt D, Weber M. Tumorspezifische und symptomorientierte Therapie maligner Gliome. Zeitschrift für Palliativmedizin 2006; 7:11-18.
   
Thömke F, Marx J J, Sauer O, Hundsberger T, Hägele S, Wiechelt J, Weilemann S L. Observations on comatose survivors of cardiopulmonary resuscitation with generalized myoclonus. BMC neurology 2005; 5:14.
   
Thömke F, Marx J, Hundsberger T, Sauer O, Hägele-Link S, Weileman S. Der „myoklonische Status epilepticus“ nach kardiopulmonaler Reanimation. Intensivmedizin 2004; 41:592-597.
   
Hundsberger T, Koch D, Klimpe S, Schlegel U. Temozolomid in der Behandlung maligner Gliome. Aktuelle Neurologie 2003; 30:184-187.
   
Thömke F, Weilemann S L, Hundsberger T, Marx J, Sauer O, Hägele-Link S, Dieterich M. Verlaufsveränderungen des Burst-Suppression-EEG bei hypoxischer Hirnschädigung nach kardiopulmonaler Reanimation. Klinische Neurophysiologie 2003; 34:86-93.
   
Vogt T, Nill M, Hundsberger T. Thalidomidinduzierte Polyneuropathie. Aktuelle Neurologie 2002; 29:149-152.
   
Hundsberger T, Thömke F, Hopf H C, Fitzek C. Symmetrical infarction of the cervical spinal cord due to spontaneous bilateral vertebral artery dissection. Stroke; a journal of cerebral circulation 1998; 29:1742.
   
Hundsberger T, Braun V, Weidmann M, Leukel P, Sauerborn M, von Eichel-Streiber C. Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile. European journal of biochemistry / FEBS 1997; 244:735-42.
   
Braun V, Hundsberger T, Leukel P, Sauerborn M, von Eichel-Streiber C. Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene 1996; 181:29-38.
   
Hundsberger T (2011). Brainstem tumors. In Brainstem disorders (pp. 255-271). Berlin Heidelberg: Springer- Verlag.
   
Hundsberger T, & Wiewrodt D (2008). Hirnstammtumoren. In Erkrankungen des Hirnstamms (pp. 243-258): Schattauer Verlag (Stuttgart, New York).
   
Vehoff J, Hägele-Link S, Humm A, Müller S, Sauter R, Tettenborn B, & Hundsberger T (2017). Heart rate variability decreases after 3 months of sustained treatment with fingolimod in patients with multiple sclerosis: a prospective clinical trial. In Session PRS2102 Autonomic nervous system 2 (pp. 2013): EAN.
   
Hundsberger T (2016). Anaplastische Gliome und ältere Glioblastompatienten: Verbesserte Überlebenszeit durch Therapieintensivierung. In Leading Opinions: Neurologie & Psychiatrie (pp. 114-116): Universimed.
   
Leupold D, Schilg-Hafer L, Felbecker A, Zieglgänsberger D, Tettenborn B, & Hundsberger T (2016). Chronic inflammatory demyelinating polyneuropathy - still a challenging diagnosis. In European Journal of Neurology (pp. 908): Wiley.
   
Hundsberger T (2016). Spontaneous multifocal cervical liquor leakage causing an intracranial hypotension syndrome. In SANP (pp. 186, P 10): www.asnp.ch.
   
Leupold D, Schilg-Hafer L, Felbecker A, Tettenborn B, & Hundsberger T (2016). Neuronal ganglia as a cause of peripheral nerve lesion. In Swiss Medical Weekly (pp. 37S): EMH Media.
   
Felbecker A, Leupold D, & Hundsberger T (2016). Nerve ultrasound findings in a patient with Charcot-Marie-Tooth (CMT) Disease type 4C. In European Journal of Neurology (pp. 768): Wiley.
   
Leupold D, Schilg-Hafer L, Felbecker A, Zieglgänsberger D, Tettenborn B, & Hundsberger T (2015). Chronic inflammatory demyelinating polyneuropathy- still a challenging diagnosis. In : Swiss Archives of Neurology and Psychiatry.
   
Hundsberger T (2015). Nerve sonography guided diagnosis of painful peroneal palsies caused by in-traneural ganglia- a case series. In Klinische Neurophysiologie (pp. 194): Thieme.
   
Hundsberger T (2015). Schweizerisch-österreichische Neuroonkologie-Tagung: Erfahrungsaustausch unter Kollegen. In Leading Opinions: Neurologie & Psychiatrie (pp. 14): 17.
   
Leupold D, Felbecker A, Tettenborn B, & Hundsberger T (2015). Neurosonographic findings in non-systemic vasculitic neuropathy. In (pp. 1): Swiss Archives of Neurology and Psychiatry.
   
prochnicki a, Zieglgänsberger D, Vehoff J, Müller S, Tettenborn B, & Hundsberger T (2015). Glioblastoma multiforme: Chameleon of neurology A case report. In (pp. 1).
   
Felbecker A, Schilg-Hafer L, Hägele-Link S, Gers B, Weber J, Tettenborn B, & Hundsberger T (2014). Detection of Intraneural Ganglia With Nerve Sonography as a Cause for Painful Peroneal Palsy: a Case Series and Review of the Literature. In Swiss Medical Forum (pp. 66): Schweizerischer Ärzteverlag.
   
Hundsberger T (2014). Long-Term Interruption of Enzyme Replacement Therapy with rhGAA in Pompe Disease Leads to Irreversible Clinical Decline. In Volume 2, Sppl. 1/2015 (pp. 20): Journal of Neuromuscular Diseases,.
   
Kapauer M, Müller-Westermann J, Hollenstein M, Hundsberger T, & Tettenborn B (2013). EBV-assoziiertes, primäres B-Zell-Non-Hodgkin-Lymphom des ZNS (PCNSL) nach Lebertrans-plantation. In .
   
Hundsberger T (2013). Neuroonkologie – ASCO 2013: Erst- und Rezidivbehandlung von Glioblastomen – Ernüchterung durch negative Phase-III-Studien. In Leading Opinions: Hämatologie & Onkologie 4/13 (pp. 118-120): Universimed.
   
Leupold D, Schilg-Hafer L, Hundsberger T, Tettenborn B, & Felbecker A (2013). Zungenmyokymien- Drei Fälle, verschiedene Ätiologien. In .
   
 
page 1 of 2